Dronabinol

Routes
Oral (PO)
Half-Life (t½)
PO: 2.75h
Formula
C21H30O2
Molecular Weight
314.46 g/mol
PubChem CID
16078
Aliases
Marinol

Pharmacological Mechanism

Synthetic Δ9-THC — same CB1/CB2 partial agonism. FDA-approved for chemotherapy-induced nausea + AIDS-related anorexia. Schedule III for the synthetic; CB1-mediated dysphoria + tachycardia limit dose escalation.

Half-Life & Elimination Curve (PO: 2.75h)

100%50%25%12.5%0%0h0×t½2.75h1×t½5.5h2×t½8.25h3×t½11h4×t½13.8h5×t½0×t½ (0h): 100% remaining (~0.356 µg/L)1×t½ (2.75h): 50% remaining (~0.178 µg/L)2×t½ (5.5h): 25% remaining (~0.089 µg/L)3×t½ (8.25h): 12.5% remaining (~0.0445 µg/L)4×t½ (11h): 6.3% remaining (~0.0223 µg/L)5×t½ (13.8h): 3.1% remaining (~0.0111 µg/L)
Plasma (PO)t½ Decay (2.75h)Effect Site (ke0)
  • 0×t½0h100% (0.356 µg/L)
  • 1×t½2.75h50% (0.178 µg/L)
  • 2×t½5.5h25% (0.089 µg/L)
  • 3×t½8.25h12.5% (0.0445 µg/L)
  • 4×t½11h6.3% (0.0223 µg/L)
  • 5×t½13.8h3.1% (0.0111 µg/L)
Elimination t½2.75h (PO)
Rate Constant (ke)0.252 h⁻¹
Time to Peak (Tmax)2.76h
Est. Peak (Cmax)0.356 µg/L
Clearance (CL)176 L/h
97% Washout (5×t½)13.8h

Dosing Guidelines

Pharmacokinetic Parameters

Receptor Binding & Occupancy

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References